Life Technologies appoints IMGM Laboratories as first certified Service Provider for the Ion Torrent Personal Genome Machine (PGM) in Germany

IMGM Laboratories GmbH (IMGM) launches full range of professional next generation sequencing (NGS) services harnessing the power of Ion Torrent's new semiconductor sequencing technology

Martinsried, (PresseBox) - By passing all requirements to become a certified service provider, IMGM, clearly demonstrated its capability to provide customers with high quality sequencing data using the PGM platform.

IMGM's service portfolio covers standard applications such as targeted resequencing, whole genome sequencing, de-novo sequencing or metagenomics. In addition, pre-designed gene panels (e.g. Ion AmpliSeq™ Comprehensive Cancer Panel, Ion AmpliSeq™ Inherited Disease Panel) are available to detect known and new mutations in research studies using standard or Formalin-fixed and Paraffin-embedded (FFPE) material.

"One of our real strengths is to develop custom content for targeted resequencing applications" said Ralph Oehlmann, Director Business Development at IMGM. "Customers can hand us a list of genes and we will run it through the IMGM Assay Development Pipeline or use the Ion AmpliSeq Designer Platform to create the perfect primer set for their application. This taken together with a high degree of flexibility, cost-effectiveness and short turn-around-times offered by the Ion Torrent platform, allows our customers to take the fast track to excellent next-generation sequencing data for their project."

"We're very pleased to welcome IMGM Laboratories GmbH to the growing Ion family as an Ion Torrent Authorized Customer Service Provider," said Maneesh Jain, vice president of Marketing and Business Development at Life Technologies.
Investment in Ion Torrent’s semiconductor sequencing technology is yet another example for IMGM’s commitment to innovation and the willingness to offer their customers the best services based on latest technologies.

IMGM Laboratories GmbH

IMGM, one of Europe's leading outsourcing companies, offers advanced genomic services tailored to the needs of customers from pharma, diagnostics, academia, and biotech. IMGM gained wide acceptance for its excellent genome-wide gene expression analyses (microarrays) and focused gene expression studies (quantitative real-time polymerase chain reaction, qPCR). Expert bioinformatics and understandable reports adding further value to these services. IMGM is accredited according to DIN EN ISO/IEC 17025 with a full accreditation for gene expression analysis based on microarrays and qPCR.

For more information on IMGM's service portfolio, please visit www.imgm.com.

Press releases you might also be interested in

Weitere Informationen zum Thema "Forschung und Entwicklung":

Künstliche Intelligenz entwächst der Experimentierphase

Im Rah­men ei­ner Stu­die hat In­fo­sys un­ter­sucht, wel­che Aus­wir­kun­gen Künst­li­che In­tel­li­genz (KI) in der Pra­xis hat. Da­bei stand vor al­lem der Ein­fluss auf den Re­turn-on-In­vest­ment (ROI), Ar­beit­neh­mer und Füh­rungs­kräf­te im Mit­tel­punkt.

Weiterlesen

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.